SINOVAC BIOTECH LTD
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $488.2M | $335.3M | $1.12B | $3.88B | $11.61B | $1.04B | $152.7M | $158.2M |
| Accounts Receivable | $286.3M | $300.9M | $424.9M | $486.6M | $942.7M | $253.5M | $113.7M | $74.5M |
| Inventory | $94.3M | $96.9M | $135.6M | $175.3M | $391.1M | $105.8M | $27.8M | $25.1M |
| Total Current Assets | $7.06B | $10.64B | $11.60B | $11.30B | $14.94B | $1.56B | $349.6M | $284.2M |
| Property, Plant & Equipment | $706.1M | $881.0M | $952.0M | $989.7M | $855.0M | $200.4M | $74.3M | $70.9M |
| Goodwill | $12.6M | $27.5M | $0 | $0 | $0 | — | — | — |
| Intangible Assets (Excl. Goodwill) | $77.7M | $122.6M | $8.5M | $9.7M | $1.5M | $1.5M | — | — |
| Total Assets | $8.54B | $12.34B | $13.61B | $14.03B | $16.76B | $1.90B | $452.3M | $369.8M |
| Liabilities | ||||||||
| Accounts Payable | $16.2M | $12.3M | $12.9M | $19.9M | $58.5M | $30.5M | $5.8M | $5.5M |
| Total Current Liabilities | $1.54B | $1.45B | $1.29B | $1.26B | $2.52B | $679.6M | $87.2M | $58.2M |
| Long-Term Debt | $494.9M | $375.8M | $253.9M | $11.8M | $15.8M | $35.1M | $5.9M | $7.2M |
| Total Liabilities | $2.15B | $2.04B | $1.97B | $1.79B | $3.21B | $781.2M | $100.1M | $77.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.82B | $6.84B | $6.79B | $6.80B | $6.81B | $144.2M | $56.7M | $23.8M |
| Total Stockholders' Equity | $4.44B | $8.26B | $8.32B | $8.49B | $9.00B | $746.5M | $294.0M | $253.4M |